Sarepta and Roche halt DMD gene therapy’s use after second death
Serepta and global partner Roche have discontinued the commercial and clinical use of Duchenne muscular dystrophy (DMD) gene therapy Elevidys…
News
J&J reports results from antibody combo trial for MM patients
Genmab announces Phase Ib/II trial outcomes of epcoritamab combo for DLBCL
Tough funding environment is impacting trial activity in the US, expert says
Bavarian Nordic launches chikungunya vaccine trial for paediatric population
Novo Nordisk ramps up obesity fight, advances amycretin to Phase III
Novartis reports positive results from Phase IIIB study of iptacopan for PNH
AI could personalise clinical trial consent, but privacy concerns remain
